COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin Treatment (LOWHDL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02153879
Recruitment Status : Completed
First Posted : June 3, 2014
Last Update Posted : June 3, 2014
Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders
Information provided by (Responsible Party):
LUIS MASANA, MD, Institut Investigacio Sanitaria Pere Virgili

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2011
Actual Study Completion Date : December 2013